Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells

Zhang,Kun-Song; Zhou,Qi; Wang,Ya-Feng; Liang,Li-Jian

doi:10.3892/or.2013.2560

Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells

Authors:
- Kun-Song Zhang
- Qi Zhou
- Ya-Feng Wang
- Li-Jian Liang
View Affiliations

Affiliations: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: June 21, 2013 https://doi.org/10.3892/or.2013.2560
Pages: 1430-1438

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore possible gene therapy for hilar cholangiocarcinoma by detecting the activation of the Wnt signaling pathway in 4 cholangiocarcinoma cell lines and inhibiting its expression by RNA interference (RNAi) targeting key factors of this pathway. The expression levels of the Wnt pathway-related factors, Wnt2, Wnt3, β-catenin and transcription factor 4, and its target genes, c-myc and cyclin D1, in 4 cholangiocarcinoma cell lines were detected by RT-PCR, western blotting and immunofluorescence microscopy. After transfection of siRNAs targeting Wnt2 and β-catenin into FRH0201 cells, the expression of the Wnt pathway-related factors and its target genes was again detected, and the cell cycle distribution, apoptosis and proliferation were analyzed by flow cytometry and MTT assay. Activation of the Wnt pathway and the expression of its target genes were detected in all 4 cell lines at various levels. After siRNA transfection, the expression of the target genes in the FRH0201 cells was significantly downregulated. In addition, the Wnt pathway was blocked, cell apoptosis was enhanced and cell proliferation was suppressed. In conclusion, the Wnt signaling pathway is activated in cholangiocarcinoma cells. RNAi technology targeting Wnt2 and β-catenin may be a possible gene therapy for hilar cholangiocarcinoma.

View Figures

View References

1	Saxena A, Chua TC, Chu FC and Morris DL: Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 202:310–320. 2011. View Article : Google Scholar : PubMed/NCBI
2	Lu D, Zhao Y, Tawatao R, et al: Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 101:3118–3123. 2004. View Article : Google Scholar : PubMed/NCBI
3	Ilyas M: Wnt signalling and the mechanistic basis of tumour development. J Pathol. 205:130–144. 2005. View Article : Google Scholar : PubMed/NCBI
4	Monga SP, Monga HK, Tan X, Mulé K, Pediaditakis P and Michalopoulos GK: Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology. 124:202–216. 2003. View Article : Google Scholar : PubMed/NCBI
5	Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK and Monga SP: Beta-catenin is temporally regulated during normal liver development. Gastroenterology. 126:1134–1146. 2004. View Article : Google Scholar : PubMed/NCBI
6	Monga SP, Pediaditakis P, Mule K, Stolz DB and Michalopoulos GK: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology. 33:1098–1109. 2001. View Article : Google Scholar : PubMed/NCBI
7	Benhamouche S, Decaens T, Godard C, et al: Apc tumor suppressor gene is the ‘zonation-keeper’ of mouse liver. Dev Cell. 10:759–770. 2006.
8	Funato Y, Michiue T, Asashima M and Miki H: The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol. 8:501–508. 2006. View Article : Google Scholar : PubMed/NCBI
9	Lian Z, Liu J, Li L, et al: Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology. 43:415–424. 2006. View Article : Google Scholar : PubMed/NCBI
10	Higashi N, Kojima N, Miura M, Imai K, Sato M and Senoo H: Cell-cell junctions between mammalian (human and rat) hepatic stellate cells. Cell Tissue Res. 317:35–43. 2004. View Article : Google Scholar : PubMed/NCBI
11	Guan CN, Chen XM, Lou HQ, Liao XH, Chen BY and Zhang PW: Clinical significance of axin and beta-catenin protein expression in primary hepatocellular carcinomas. Asian Pac J Cancer Prev. 13:677–681. 2012. View Article : Google Scholar : PubMed/NCBI
12	Kaur P, Mani S, Cros MP, et al: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol. 33:325–336. 2012. View Article : Google Scholar : PubMed/NCBI
13	Loeppen S, Koehle C, Buchmann A and Schwarz M: A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis. 26:239–248. 2005. View Article : Google Scholar : PubMed/NCBI
14	Tien LT, Ito M, Nakao M, et al: Expression of beta-catenin in hepatocellular carcinoma. World J Gastroenterol. 11:2398–2401. 2005. View Article : Google Scholar : PubMed/NCBI
15	Tokumoto N, Ikeda S, Ishizaki Y, et al: Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol. 27:973–980. 2005.PubMed/NCBI
16	Sugimachi K, Taguchi K, Aishima S, et al: Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol. 14:900–905. 2001. View Article : Google Scholar : PubMed/NCBI
17	Ku JL, Yoon KA, Kim IJ, et al: Establishment and characterisation of six human biliary tract cancer cell lines. Br J Cancer. 87:187–193. 2002.PubMed/NCBI
18	Takiyama I, Terashima M, Ikeda K, et al: Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1). Oncol Rep. 5:463–467. 1998.PubMed/NCBI
19	Tang WH, Yuan ST, Wang BS, Lu LJ, Ding J and Yuan ZR: Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue. J Exp Clin Cancer Res. 23:661–667. 2004.PubMed/NCBI
20	Uematsu K, He B, You L, Xu Z, McCormick F and Jablons DM: Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
21	Davies JA, Ladomery M, Hohenstein P, et al: Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet. 13:235–246. 2004. View Article : Google Scholar
22	Sangkhathat S, Kusafuka T, Miao J, et al: In vitro RNA interference against β-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol. 28:715–722. 2006.
23	Kim M, Lee HC, Tsedensodnom O, et al: Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol. 48:780–791. 2008. View Article : Google Scholar : PubMed/NCBI
24	Mazieres J, You L, He B, et al: Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer. 117:326–332. 2005. View Article : Google Scholar : PubMed/NCBI
25	Zhao P, Lu Y, Zhong M, Liu L and Li B: Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Acta Oncol. 47:1557–1563. 2008. View Article : Google Scholar : PubMed/NCBI
26	El-Kady A, Sun Y, Li YX and Liao DJ: Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families. J Carcinog. 10:242011.PubMed/NCBI